These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 30620725

  • 1. Reduced expression of phosphatase PTPN2 promotes pathogenic conversion of Tregs in autoimmunity.
    Svensson MN, Doody KM, Schmiedel BJ, Bhattacharyya S, Panwar B, Wiede F, Yang S, Santelli E, Wu DJ, Sacchetti C, Gujar R, Seumois G, Kiosses WB, Aubry I, Kim G, Mydel P, Sakaguchi S, Kronenberg M, Tiganis T, Tremblay ML, Ay F, Vijayanand P, Bottini N.
    J Clin Invest; 2019 Mar 01; 129(3):1193-1210. PubMed ID: 30620725
    [Abstract] [Full Text] [Related]

  • 2. PTPN2 links colonic and joint inflammation in experimental autoimmune arthritis.
    Hsieh WC, Svensson MN, Zoccheddu M, Tremblay ML, Sakaguchi S, Stanford SM, Bottini N.
    JCI Insight; 2020 Oct 15; 5(20):. PubMed ID: 33055428
    [Abstract] [Full Text] [Related]

  • 3. Generation of RORγt+ Antigen-Specific T Regulatory 17 Cells from Foxp3+ Precursors in Autoimmunity.
    Kim BS, Lu H, Ichiyama K, Chen X, Zhang YB, Mistry NA, Tanaka K, Lee YH, Nurieva R, Zhang L, Yang X, Chung Y, Jin W, Chang SH, Dong C.
    Cell Rep; 2017 Oct 03; 21(1):195-207. PubMed ID: 28978473
    [Abstract] [Full Text] [Related]

  • 4. Polyfunctional, Pathogenic CD161+ Th17 Lineage Cells Are Resistant to Regulatory T Cell-Mediated Suppression in the Context of Autoimmunity.
    Basdeo SA, Moran B, Cluxton D, Canavan M, McCormick J, Connolly M, Orr C, Mills KH, Veale DJ, Fearon U, Fletcher JM.
    J Immunol; 2015 Jul 15; 195(2):528-40. PubMed ID: 26062995
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-448 promotes multiple sclerosis development through induction of Th17 response through targeting protein tyrosine phosphatase non-receptor type 2 (PTPN2).
    Wu R, He Q, Chen H, Xu M, Zhao N, Xiao Y, Tu QQ, Zhang W, Bi X.
    Biochem Biophys Res Commun; 2017 May 06; 486(3):759-766. PubMed ID: 28342869
    [Abstract] [Full Text] [Related]

  • 6. RORγt expression in Tregs promotes systemic lupus erythematosus via IL-17 secretion, alteration of Treg phenotype and suppression of Th2 responses.
    Kluger MA, Nosko A, Ramcke T, Goerke B, Meyer MC, Wegscheid C, Luig M, Tiegs G, Stahl RA, Steinmetz OM.
    Clin Exp Immunol; 2017 Apr 06; 188(1):63-78. PubMed ID: 27880975
    [Abstract] [Full Text] [Related]

  • 7. Foxp3(+) T cells expressing RORγt represent a stable regulatory T-cell effector lineage with enhanced suppressive capacity during intestinal inflammation.
    Yang BH, Hagemann S, Mamareli P, Lauer U, Hoffmann U, Beckstette M, Föhse L, Prinz I, Pezoldt J, Suerbaum S, Sparwasser T, Hamann A, Floess S, Huehn J, Lochner M.
    Mucosal Immunol; 2016 Mar 06; 9(2):444-57. PubMed ID: 26307665
    [Abstract] [Full Text] [Related]

  • 8. IL-10 suppresses Th17 cells and promotes regulatory T cells in the CD4+ T cell population of rheumatoid arthritis patients.
    Heo YJ, Joo YB, Oh HJ, Park MK, Heo YM, Cho ML, Kwok SK, Ju JH, Park KS, Cho SG, Park SH, Kim HY, Min JK.
    Immunol Lett; 2010 Jan 04; 127(2):150-6. PubMed ID: 19895848
    [Abstract] [Full Text] [Related]

  • 9. Upregulated Expression of microRNA-16 Correlates with Th17/Treg Cell Imbalance in Patients with Rheumatoid Arthritis.
    Wu YH, Liu W, Xue B, Zhang L, Liu XY, Liu B, Wang Y, Cai Y, Duan R.
    DNA Cell Biol; 2016 Dec 04; 35(12):853-860. PubMed ID: 27875659
    [Abstract] [Full Text] [Related]

  • 10. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
    Nishihara M, Ogura H, Ueda N, Tsuruoka M, Kitabayashi C, Tsuji F, Aono H, Ishihara K, Huseby E, Betz UA, Murakami M, Hirano T.
    Int Immunol; 2007 Jun 04; 19(6):695-702. PubMed ID: 17493959
    [Abstract] [Full Text] [Related]

  • 11. PTPN2-deficiency exacerbates T follicular helper cell and B cell responses and promotes the development of autoimmunity.
    Wiede F, Sacirbegovic F, Leong YA, Yu D, Tiganis T.
    J Autoimmun; 2017 Jan 04; 76():85-100. PubMed ID: 27658548
    [Abstract] [Full Text] [Related]

  • 12. RORγt-Expressing Tregs Drive the Growth of Colitis-Associated Colorectal Cancer by Controlling IL6 in Dendritic Cells.
    Rizzo A, Di Giovangiulio M, Stolfi C, Franzè E, Fehling HJ, Carsetti R, Giorda E, Colantoni A, Ortenzi A, Rugge M, Mescoli C, Monteleone G, Fantini MC.
    Cancer Immunol Res; 2018 Sep 04; 6(9):1082-1092. PubMed ID: 29991500
    [Abstract] [Full Text] [Related]

  • 13. An autoimmune-associated variant in PTPN2 reveals an impairment of IL-2R signaling in CD4(+) T cells.
    Long SA, Cerosaletti K, Wan JY, Ho JC, Tatum M, Wei S, Shilling HG, Buckner JH.
    Genes Immun; 2011 Mar 04; 12(2):116-25. PubMed ID: 21179116
    [Abstract] [Full Text] [Related]

  • 14. Polymorphism of Foxp3 gene affects the frequency of regulatory T cells and disease activity in patients with rheumatoid arthritis in Iranian population.
    Hashemi V, Farrokhi AS, Tanomand A, Babaloo Z, Hojjat-Farsangi M, Anvari E, Tahoori MT, Ezzeddini R, Hosseini A, Gharibi T, Ghalamfarsa G, Jadidi-Niaragh F.
    Immunol Lett; 2018 Dec 04; 204():16-22. PubMed ID: 30292536
    [Abstract] [Full Text] [Related]

  • 15. Aged regulatory T cells protect from autoimmune inflammation despite reduced STAT3 activation and decreased constraint of IL-17 producing T cells.
    Sun L, Hurez VJ, Thibodeaux SR, Kious MJ, Liu A, Lin P, Murthy K, Pandeswara S, Shin T, Curiel TJ.
    Aging Cell; 2012 Jun 04; 11(3):509-19. PubMed ID: 22372596
    [Abstract] [Full Text] [Related]

  • 16. PTPN2 controls differentiation of CD4⁺ T cells and limits intestinal inflammation and intestinal dysbiosis.
    Spalinger MR, Kasper S, Chassard C, Raselli T, Frey-Wagner I, Gottier C, Lang S, Atrott K, Vavricka SR, Mair F, Becher B, Lacroix C, Fried M, Rogler G, Scharl M.
    Mucosal Immunol; 2015 Jul 04; 8(4):918-29. PubMed ID: 25492475
    [Abstract] [Full Text] [Related]

  • 17. Cell-penetrable mouse forkhead box protein 3 alleviates experimental arthritis in mice by up-regulating regulatory T cells.
    Liu X, Ji B, Sun M, Wu W, Huang L, Sun A, Zong Y, Xia S, Shi L, Qian H, Xu W, Shao Q.
    Clin Exp Immunol; 2015 Jul 04; 181(1):87-99. PubMed ID: 25809415
    [Abstract] [Full Text] [Related]

  • 18. Anti-CD4 treatment inhibits autoimmunity in scurfy mice through the attenuation of co-stimulatory signals.
    Mayer CT, Tian L, Hesse C, Kühl AA, Swallow M, Kruse F, Thiele M, Gershwin ME, Liston A, Sparwasser T.
    J Autoimmun; 2014 May 04; 50():23-32. PubMed ID: 24075450
    [Abstract] [Full Text] [Related]

  • 19. Increased CD4+CD45RA-FoxP3low cells alter the balance between Treg and Th17 cells in colitis mice.
    Ma YH, Zhang J, Chen X, Xie YF, Pang YH, Liu XJ.
    World J Gastroenterol; 2016 Nov 14; 22(42):9356-9367. PubMed ID: 27895423
    [Abstract] [Full Text] [Related]

  • 20. Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin.
    Bovenschen HJ, van de Kerkhof PC, van Erp PE, Woestenenk R, Joosten I, Koenen HJ.
    J Invest Dermatol; 2011 Sep 14; 131(9):1853-60. PubMed ID: 21654831
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.